Company intelligence / Profile preview

DEK

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

DEK Pharmaceuticals is an Indian pharmaceutical company focused on the development, manufacturing, and distribution of a wide range of generic pharmaceutical products. The company provides essential medicines across various therapeutic categories, including antibiotics, analgesics, and treatments for chronic conditions. DEK Pharmaceuticals operates with a focus on providing affordable healthcare solutions primarily within the Indian domestic market. Their business model encompasses both the production of finished dosage forms and the distribution of pharmaceutical formulations to healthcare providers.

Therapeutic areas: Infectious DiseasesCardiovascularNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on DEK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEK.

Explore the full profile